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Aberrant hexanucleotide repeat expansions in
C9orf72 are the most common genetic change un-
derlying amyotrophic lateral sclerosis (ALS) and
frontotemporal dementia (FTD). RNA transcripts
containing these expansions undergo repeat-associ-
ated non-ATG translation (RAN-T) to form five dipep-
tide repeat proteins (DPRs). DPRs are found as
aggregates throughout the CNS of C9orf72-ALS/
FTD patients, and some cause degeneration when
expressed in vitro in neuronal cultures and in vivo
in animal models. The spread of characteristic dis-
ease-related proteins drives the progression of pa-
thology in many neurodegenerative diseases. While
DPR toxic mechanisms continue to be investigated,
the potential for DPRs to spread has yet to be deter-
mined. Using different experimental cell culture plat-
forms, including spinal motor neurons derived from
induced pluripotent stem cells from C9orf72-ALS pa-
tients, we found evidence for cell-to-cell spreading
of DPRs via exosome-dependent and exosome-
independent pathways, which may be relevant to
disease.
INTRODUCTION
Abnormal intronic hexanucleotide (GGGGCC/CCCCGG) repeat
expansions (HREs) in the C9orf72 gene are the most common
genetic cause for both amyotrophic lateral sclerosis (ALS), a mo-
tor neuron degenerative disease, and frontotemporal dementia
(FTD), a form of dementia characterized by selective deteriora-
tion of the frontal and temporal lobes (DeJesus-Hernandez
et al., 2011; Renton et al., 2011). The HREs result in three poten-
tial pathogenic hallmarks of disease. First, decreased C9orf72
mRNA expression levels in patients suggest a loss-of-function
mechanism (Ciura et al., 2013; Therrien et al., 2013). Second,
RNA transcripts from the HREs potentially gain a toxic function
by sequestering RNA-binding proteins in foci (Gendron et al.,
2014) and/or inhibiting transcription through the formation ofCe
This is an open access article under the CC BY-NRNA-DNA hybrids (Gitler and Tsuiji, 2016). Lastly, both sense
and antisense RNA transcripts can undergo non-canonical
repeat-associated non-ATG translation (RAN-T), generating
five potentially toxic dipeptide repeat protein species (DPRs):
poly(glycine-alanine) [poly(GA)], poly(glycine-proline) [poly(GP)],
poly(glycine-arginine) [poly(GR)], poly(proline-alanine) [poly(PA)],
and poly(proline-arginine) [poly(PR)] (Gitler and Tsuiji, 2016).
DPR inclusions were reported in different CNS areas of
C9orf72-ALS/FTD patients (Ash et al., 2013; Gendron et al.,
2013; Mori et al., 2013a, 2013b; Zu et al., 2013). In addition,
pervasive DPR pathology is found during presentation of initial
symptoms of disease, preceding onset of pathology such as
TDP-43 inclusions (Baborie et al., 2015; Proudfoot et al., 2014).
DPRs alter cellular functions and induce toxicity in different
ways in various models. In primary neurons and fly models, the
arginine-rich DPRs display the highest toxicity. Poly(GR), which
localizes in the cytoplasm and aggregates in the nucleus, and
poly(PR), which exclusively aggregates in the nucleus, trigger
nucleolar stress, nuclear transport defects, RNA processing al-
terations, and protein mislocalization (Gitler and Tsuiji, 2016).
Poly(GA) is also toxic through proteasome impairment, aggrega-
tion of Unc119, and impairment of HR23 and nucleocytoplasmic
transport proteins (May et al., 2014; Zhang et al., 2014, 2016). In
contrast, marginal and no toxicity have been associated with
poly(GP) and poly(PA), respectively (Wen et al., 2014; Zu et al.,
2013). These findings have solidified the importance of DPR
pathology in C9orf72-ALS/FTD.
The progression of many neurodegenerative diseases,
including ALS, is thought to be driven by cell-to-cell transmission
of disease-related proteins, which leads to seeded aggregation
and template-directed misfolding. A growing body of evidence
has uncovered a propensity for disease-relevant proteins such
as poly-glutamine, a-synuclein, b-amyloid, SOD1, and TDP-43
to be transmitted from cell to cell and to seed template
nucleation (Feiler et al., 2015; Gallegos et al., 2015; Kanouchi
et al., 2012; Nath et al., 2012; Ren et al., 2009; Silverman
et al., 2016). Mechanisms of transmission involve secretion
of exosomes (Bellingham et al., 2012; Danzer et al., 2012;
Pant et al., 2012; Saman et al., 2012), tunneling nanotubes, hemi-
channels between cells, exocytosis and endocytosis of pro-
teins, and phagocytosis of infected cells or cellular debris
(Costanzo and Zurzolo, 2013; Gallegos et al., 2015). Thesell Reports 17, 645–652, October 11, 2016 ª 2016 The Authors. 645
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Figure 1. In Vitro Transmission of DPRs from NSC34 Cells to Cortical Neurons and from Cortical Neurons to Astrocytes
(A–C) Schematics of experimental workflow.
(A) Bottom: transfected NSC34 cells transmitted DPRs to cortical neurons in a transwell system. All DPR species were detected in cortical neurons besides
poly(PR). Nuclei were stained with DAPI (blue), green represents DPRs, and red represents MAP2+ neurons.
(B) Bottom: representative confocal images show transmission of all DPR species (GFP tagged) from cortical neurons to astrocytes. Cells were stained with DAPI
(blue for nuclei), DPRs (GFP, shown in green), GFAP (red), and MAP2 (cyan). There was negligible MAP2 staining in GA, GR, and PR groups, suggestive of
extensive neuronal death.
(C) Bottom: cells were stained with DAPI (blue for nuclei), DPRs (GFP, shown in green), and GFAP (red) for astrocytes. Small or low fluorescent aggregates are
marked by arrows. Scale bars, 50 mm.protein-spreading modalities are commonly interpreted as a
mechanism underlying the progressive nature of many neurode-
generative diseases.
Although progress is being made onmechanisms behind DPR
toxicity, their potential to transmit between cells is untested thus
far. The potential for DPR transmission was hinted at for a low-
repeat-length, synthetic poly(GA) using N2a neuroblastoma cells
(Chang et al., 2016). Poly(GP) has also been detected in patients’
cerebrospinal fluid (CSF), suggesting active secretion (Su et al.,
2014). In addition, neuropathological analysis of C9orf72-ALS/
FTD autopsy brains demonstrated two types of aggregation
and localization patterns for cells containing DPRs: high-density
clusters and isolated cells (Zu et al., 2013). This not only suggests
specific foci in which RAN-T occurs but also raises the hypothe-
sis that DPRs produced in these foci could spread to neighboring
areas. Furthermore, DPRs are detected as insoluble aggregates
in human tissue, and most form aggregates in vitro, a common
pathological hallmark of disease-relevant proteins found to
spread (Brettschneider et al., 2015). Using live-cell microscopy,
we observed that toxic poly(PR) aggregates persist in the dish
long after the expressing neurons broke up and died (Wen646 Cell Reports 17, 645–652, October 11, 2016et al., 2014), again suggesting that these aggregates might be
taken up by other cells. Based on these lines of evidence, we
hypothesized that DPRs could undergo cell-to-cell transmission
between CNS-resident cell types. Using a variety of cell culture
platforms, we report here evidence for exosome-dependent
and exosome-independent cell-to-cell transmission for all
C9-DPRs.
RESULTS
DPRs Can Be Transmitted to Neurons and Glia Cells
To test in vitro the hypothesis that DPRs are transmissible, we
used constructs encoding GFP-tagged poly(GA)50, poly(GP)50,
poly(GR)50, poly(PA)50, and poly(PR)50 dipeptides (Wen et al.,
2014). Our first approach was to use motor neuron-like NSC34
cells cultured in transwells on amesh surface (0.4 mmpores) (Fig-
ure 1A) and transfected with GFP or GFP-DPR encoding con-
structs. NSC34 cells were extensively washed twenty-four hr
later and the transwells were placed intowells platedwithmature
primary cortical neurons (DIV10). Forty-eight hr later, confocal
microscopy analysis revealed the presence of DPRs in cortical
neurons, suggesting that transmission occurred. Staining was
absent from the GFP-only encoding group, indicating that the
acquisition of DPRs was not due to unintended transfection
from residual construct particles (Figure S1A). GA showed
distinct cytoplasmic aggregates in recipient cortical neurons
(7% of total cortical neurons), whereas GR nuclear and cyto-
plasmic aggregates, in addition to diffuse localization, were de-
tected in 6% of cortical neurons. GP and PA displayed both
diffuse localization and cytoplasmic aggregates in recipient
cortical neurons (3% of total cortical neurons). There was
no significant evidence of PR transmission to cortical neurons
(Figure S1D).
It was reported that neurodegenerative disease-relevant pro-
teins, such as TDP-43, propagate to both neuron and glial cells
(Brettschneider et al., 2015). In addition, DPRs have been
observed in ependymal and subependymal glial cells (Schludi
et al., 2015). Seeking additional evidence of DPR transmission,
we testedwhether transmissionof thedifferentDPRscouldoccur
between neurons and glial cells. Cortical neurons were trans-
fected with GFP or GFP-DPR constructs and thoroughly washed
24 hr later when untreated primary astrocytes were seeded in the
culture plate.Confocalmicroscopy analysis performed48hr later
revealed DPR localization within astrocytes (Figure 1B), with ab-
sent GFP-only staining in astrocytes (Figure S1B). Quantification
of DPR transmission revealed that in the co-culture cell-contact
model, the percentage of cell-containing DPRs was 2-fold
highercompared to that in the transwell experiments (FigureS1E).
GA presented as cytoplasmic aggregates, whereas GR and PR
displayed as both cytoplasmic and nuclear aggregates. GP and
PA exhibited both cytoplasmic aggregates and diffuse localiza-
tion in astrocytes.
Using a different experimental approach, conditioned medium
(CM) from GFP or GFP-DPR expressing cortical neurons was
transferred to cultured astrocytes. Neuron-to-astrocyte trans-
mission was again observed, with similar DPR localization pat-
terns in the recipient cells as reported in co-cultures (Figure 1C)
and absent GFP-only transmission (Figure S1C). However,
quantification of transmission was lower (with 6%–8% of astro-
cytes displaying GA-, GR-, and PR-positive aggregates and
4% of astrocytes displaying cytoplasmic aggregates and
diffuse localization of GP and PA), as reported in the co-culture
cell-contact model, but it was similar to the transwell model (Fig-
ure S1F). DPR transmission via CM transfer also occurred to
other glia cell types, such as microglia and mature oligodendro-
cytes (Figure S2). These observations provide further evidence
for DPR transmission between CNS cell types.
Anterograde and Retrograde Transmission of DPRs
DPR aggregates are found throughout different CNS areas in
high-density clusters and isolated cells (Zu et al., 2013). In a
compartmentalized microfluidic culture system, both antero-
grade transmission and retrograde transmission of TDP-43
have been demonstrated. This could explain the complex vari-
able distribution of TDP-43 pathology in axonally connected
distant brain regions (Feiler et al., 2015). We used a similar
in vitro approach to test whether DPRs can potentially spread
between neuronal networks. Cortical neurons were cultured in
one of the microfluidic chambers (chamber 1), and their neuriteswere made to extend across microgrooves to contact cortical
neurons cultured in the opposite chamber (chamber 2) (Fig-
ure 2A). Axon projection directionality (chamber 1 to chamber 2)
was driven by applying higher hydrostatic pressure in chamber 1.
Once themicrofluidic culture was established, higher hydrostatic
pressure was applied to chamber 2 to impede anterograde
transfer of solution and material, and the projecting cortical neu-
rons in chamber 1 were transfected with DPR-encoding plas-
mids. Forty-eight hr post-transfection, DPRs were detected in
cortical neurons of chamber 2 (Figure 2B), indicating antero-
grade transfer of DPRs had occurred via the connecting neurites.
GA-, GP-, and PA-containing neurons displayed cytoplasmic ag-
gregates, while GR-containing neurons had both cytoplasmic
and nuclear aggregates. We found no evidence for PR transmis-
sion, consistent with previous evidence with the transwell plat-
form. Retrograde transmission was observed using a similar
setup but with the absence of cortical neurons in chamber 2 (Fig-
ure 2C). Upon establishment of the microfluidic culture, CM from
DPR-expressing NSC34 cells was transferred into chamber 2
while applying higher hydrostatic pressure in chamber 1 to block
retrograde transfer of solution and material. Forty-eight hr later,
all DPRs except PR were detected in cortical neurons in cham-
ber 1 (Figure 2D).
Exosome-Dependent Transmission of DPRs
Cell-to-cell transmission of proteins may occur via different mo-
dalities, such as regulated secretion by exocytosis or release
from dying cells (Costanzo and Zurzolo, 2013). Packaging and
release of microvesicles known as exosomes were implicated
as a primary mode of transmission of proteins relevant in neuro-
degenerative disease (Bellingham et al., 2012; Danzer et al.,
2012; Saman et al., 2012; Silverman et al., 2016). We demon-
strated in the transwell and microfluidic systems that direct cell
contact was not required for inter-cellular spreading of DPRs,
suggesting that neuronal cells are also capable of releasing
DPRs. To determine whether cell-contact-independent DPR
transmission implicates release of DPR-containing exosomes,
NSC34 cells were first transfected with DPR- or GFP-encoding
constructs, and then 48 hr later, exosome particles were isolated
and purified from the culture medium. Purity of the exosomal
fraction was assessed by the enrichment of specific exosomal
markers and absence of other vesicular types, such as those
derived from the Golgi (GM130), ER (calnexin), andmitochondria
(cytochrome C) (Figure 3A; Figure S3). The presence of DPRs in
exosomes was assessed by dot-blot analysis (Figure 3A; Fig-
ure S3). DPR immunopositive signals relative to markers of exo-
somes (i.e., flotillin, TSG101, and CD63) (Bellingham et al., 2012)
revealed enrichment of GA, intermediate levels of PA and GR,
low levels of GP, and very low to undetectable levels of PR.
To verify the transmission potential of DPR-containing exo-
somes, primary cortical neurons were incubated with DPR-en-
riched exosomal fractions isolated from the CM of transfected
NSC34 cells (Figure 3B). For comparison, a separate group of
cortical neurons was incubated with unprocessed CM. In both
conditions, GA, GP, GR, and PA were present with varying rates
in the cortical neurons, primarily as cytoplasmic aggregates,
indicating that neuronal uptake had occurred (Figure 3C; Figures
S3B and S3C). Significant transmission of PR was only observedCell Reports 17, 645–652, October 11, 2016 647
Figure 2. Anterograde and Retrograde Transmission of DPRs
(A and C) Schematics of the experimental design.
(B) Transfected cortical neurons in chamber 1 transmitted DPRs to cortical neurons in chamber 2.
(D) CM of DPR-expressing NSC34 cells added to chamber 2 transmitted DPRs to cortical neurons in chamber 1.
All DPRs were detected in cortical neurons, except for PR. DAPI (blue), DPRs (green), and MAP2 (red) are shown. DPR aggregates are marked by arrows. Scale
bars, 50 mm.from crude CM exposure, whereas incubation of neurons with
the respective exosomal fraction showed no significant PR
transmission.
Human iPSC-Derived sMNs Exhibit Cell-to-Cell
Transmission of DPRs
To establish whether DPR transmission also occurred in human
neurons, the co-culture and CM experimental designs previously
describedwere implementedbyusinghuman inducedpluripotent
stem cell (iPSC)-derived spinal motor neurons (sMNs). C9orf72
(two different iPSC lines, Target ALS) and control (one iPSC line,648 Cell Reports 17, 645–652, October 11, 2016Wicell) iPSC lines were differentiated into sMNs using a modified
version of a previously described protocol (Figure S4) (Maury
et al., 2015). Most differentiated neurons are ChAT and Hb9 pos-
itive. Control sMNs were transduced with a lentivirus expressing
GFP under a cytomegalovirus (CMV) promoter for identification.
We found evidence of expression of the sense strand DPRs
(GA, GR, and GP) in C9orf72 sMNs (Figures 4Aa, 4Ac, and 4Ae).
Expression of anti-sense DPRs (PA and PR) in sMNs was not de-
tected under our culturing condition; hence, we focused our anal-
ysis on GA, GR, and GP. In the co-culture system, C9orf72 sMNs
were co-cultured with GFP-expressing control sMNs and further
Figure 3. Exosome-Dependent and Exosome-Independent Transmission of DPRs
(A) Representative dot blot of the exosomal fraction isolated from CMs of NSC34 cells transfected with different DPR-encoding constructs. DPRs were detected
by GFP immunostaining. Flotillin and TSG101 were used as markers of the exosomal fraction. GM130 was used as marker of other membrane vesicle types.
(B) Experimental workflow to compare DPR transmission from the exosomal fraction and total CMs.
(C) Left: representative confocal images show transmission of DPRs to cortical neurons through CMs. Right: representative images show transmission of DPRs,
except PR, to cortical neurons through isolated exosomes.
DAPI (blue), DPRs (green), and MAP2 (red) are shown. DPR aggregates are marked by arrows. Scale bars, 50 mm.matured to day 22. Staining for the sense strand DPRs, which
have a higher concentration in vivo, revealed the presence of
GA and GR aggregates in GFP-labeled sMNs (control motor neu-
rons normally negative for their presence), indicating transmission
has occurred from the C9orf72 sMNs (Figures 4Ab, 4Ad, and 4Af).
No detectable transmission occurred in the case of GP. Similarly,
C9orf72 sMN CM applied to GFP-expressing control sMNs re-
vealed the presence of GA and GR aggregates, but the absence
of GP staining, in control sMNs (Figure 4B).
DISCUSSION
The tendency for disease-relevant proteins to spread across the
CNS has begun to be reported in neurodegenerative diseases(Costanzo and Zurzolo, 2013), shaping our understanding of
their progressive nature. In ALS, TDP-43 and SOD1 spread in-
ter-cellularly and promote seeding activity, which leads to
the misfolding of native protein species within the recipient cells
(Feiler et al., 2015; Kanouchi et al., 2012; Silverman et al., 2016).
C9-RAN-T DPRs are key pathogenic mediators of C9orf72-
linked ALS/FTD (Gitler and Tsuiji, 2016). In patients, DPRs have
been reported throughout the CNS, including the spinal cord,
frontal cortex, motor cortex, hippocampus, and cerebellum
(Schipper et al., 2015). Studies show toxicity and cellular dys-
functions resulting from some of these DPRs; however, their
ability to transmit between cells has yet to be described. Neuro-
pathological analysis of post-mortem tissues from C9orf72-ALS
patients showed that the expression of DPR aggregates has aCell Reports 17, 645–652, October 11, 2016 649
Figure 4. DPRs Transmit in iPSC-Derived sMNs
(A) Representative confocal images show transmission of sense DPR species
in co-cultures of control and C9orf72 iPSC-derived sMNs. DPR production
was verified in C9orf72 sMNs (a, c, and e). Both C9orf72 iPSC lines provide
similar results. Control sMNs, identified by GFP (green), showed the presence
of GA, GR, andGP,which are not normally present (b, d, and f). MAP2 (red) and
DPRs (cyan) are shown.
(B) Representative confocal images show transmission of sense DPR species
through CMs of C9orf72 sMNs. Green represents transduced control sMNs,
red represents MAP2+ neurons, and cyan represents DPRs.
Scale bars, 50 mm.
650 Cell Reports 17, 645–652, October 11, 2016distinct clustered pattern (Zu et al., 2013). This might suggest not
only the existence of focal areas in which RAN-T occurs but also
that, once made, DPRs can progressively pollute adjacent cells
and spread. Here, we have demonstrated intercellular transmit-
tance of DPRs by employing various in vitro cell culture platforms
and have gained initial insights into possible modalities of this
process.
We first explored DPR transmission between neurons and
from neuron to glia. All DPR species transmitted from cell to
cell, with disparate localization patterns and frequency of trans-
mission. When NSC34 cells are transfected with equal amounts
of cDNA, the arginine-rich DPRs are normally less efficiently ex-
pressed than the other DPRs (Wen et al., 2014). This lesser
expression is likely due to the arginine-rich DPR effect on protein
translation (Gitler and Tsuiji, 2016). Therefore, quantification of
frequency of transmission among different DPRs does not accu-
rately reflect differences in transmission efficiency intrinsic to the
different DPR species, but it is meant only to compare transmis-
sion efficiency among different experimental paradigms. In the
cases of GA, GR, and PR co-culture experiments, when astro-
cytes were assessed for DPR presence, there were virtually no
transfected and were sparse non-transfected neurons remaining
on the dish. Although circumstantial, this evidence suggests the
establishment of a possible toxic environment produced as a
result of changes in DPR-receiving astrocytes. Nevertheless,
this evidence does not fully support the notion that transmission
of DPRs from one cell to another is equivalent to propagation
of pathology in vivo, which likely requires template nucle-
ation. More follow-up experiments will be needed to establish
a cause-effect relationship in the DPR transmission process.
Furthermore, retrograde transmission and anterograde trans-
mission were observed for most DPRs, suggesting spread be-
tween connecting neurons in different CNS regions.
Ectopic expression of DPRs by lipofection of cells in culture
can lead to their overabundance, potentially forcing a transmis-
sion event that otherwise would not occur. However, the patho-
physiological relevance of this process was confirmed by the
observation of transmission of DPRs in iPSC-derived sMNs
from C9orf72 patients, which endogenously produce DPRs.
Cell-to-cell transmission can occur through various mecha-
nisms, such as phagocytosis, endocytosis, and exocytosis,
tunneling nanotubes, hemichannels, or microvesicle release
(Costanzo and Zurzolo, 2013). Direct cell-to-cell interaction
was not a requirement for DPR transmission, though cellular
contact was sufficient and did enhance transmission of some
DPR species. We explored transmission through release of
DPRs using transwell and microfluidic culturing systems. In
both, DPR transmission to cortical neurons was observed
except for PR, which surprisingly displayed rare to absent trans-
mission. In addition, anterograde transmission and retrograde
transmission seen in microfluidic platforms suggest that it can
occur through axon terminals, similarly to TDP-43 (Feiler et al.,
2015). In these systems, GP and PA displayed cytoplasmic ag-
gregates in the receiving neurons. In vitro, GP and PA display
diffuse localization (Wen et al., 2014). However, GP and PA are
present in aggregates in C9orf72-ALS/FTD human tissue (Ash
et al., 2013; Gendron et al., 2013; Mori et al., 2013a, 2013b; Zu
et al., 2013). This raises the possibility that GP and PA could
undergo transmission in vivo and have a different toxic profile
than their diffuse in vitro counterparts.
Exosomes have been implicated as a primary mode for
cell-to-cell transmission in many neurodegenerative diseases
(Danzer et al., 2012; Saman et al., 2012; Silverman et al.,
2016). Exosomes are vesicles (50–150 nm) released by most
mammalian cells that contain an assortment of macromole-
cules such as mRNAs, microRNAs (miRNAs), bioactive lipids,
and proteins and play a role in health and disease (Pant
et al., 2012; Raposo and Stoorvogel, 2013). We found that exo-
somes have the capability to incorporate DPRs, although PR
accumulation was negligible compared to the others. Conse-
quently, isolated exosomes transmit DPRs to cortical neu-
rons. PR was primarily transmitted in an exosome-independent
manner, likely because of its strong nuclear localization propen-
sity and highly toxic profile. However, the role and modalities of
an exosome-independent transmission for PR need to be fully
explored.
Although the precise mechanisms involved in release and
cellular uptake of DPRs still need to be investigated, we have
begun to establish the involvement of exosomes in DPR
transmission. Important questions are being investigated. For
example, can DPRs transfer across synapses in vivo, and can
this account for the propagation of pathology along neural net-
works? As current studies are extended and augmented by
new findings, it would seem that stopping the spread of DPRs,
and other disease-relevant proteins, could provide an interesting
and novel therapeutic target. Because DPRs initiate a cascade of
toxic cellular dysfunctions, preventing this cell-to-cell transmis-
sion may salvage remaining healthy cells and halt disease
progression.
EXPERIMENTAL PROCEDURES
Microfluidic Chambers
Two-chamber microfluidic devices were assembled using Colorfrost Plus
Slides as a support platform. Slides were UV sterilized, coated with poly-D-
lysine, and placed into secondary containment dishes. Following a rinse with
70% ethanol, Standard Neuron Device (150 mm microgroove barrier; Xona
Microfluidic cat. SND150) was applied to the slides. Then, 300 mL of neuronal
growth medium was added to each set of plating wells connected by a chan-
nel, observing by eye that the channel became filled with media. Primary
rat cortical neurons (20,000 cells/150 mL) were seeded into each well. The
following day, total growthmediumwas increased to 500 or 250 mL to establish
hydrostatic pressure differential in the two chambers. This ensured unidirec-
tional growth through the microgrooves during neurite and axon extension.
At the time of treatment, hydrostatic pressure was reverted to prevent cross-
over of transfection reagents.
Exosome Isolation
Exosomes from NSC34 cells were prepared using the Total Exosome Isolation
kit (Thermo Fisher Scientific #4478359) or through ultracentrifugation, as
described previously (The´ry et al., 2006). Both techniques were used initially
to ensure the highest and a purer yield of exosomes. There was no significant
difference between the yields, as determined via dot blot.
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